Asia FX Rates Futures Crypto RangeDropdown Markets1D5D1M3M6M1Y2Y Asia Dow4,172.57-61.68-1.46% Nikkei 22539,470.44-378.70-0.95% Hang Seng19,971.24-425.81-2.09% Shanghai3,391.88-69.62-2.01% Sensex82,133.12843.161.04% Singapore3,810.351.080.03% ...
EGFR structure (Photo credit: Wikipedia)ATP synthase (Photo credit: Ethan Hein) Non-small cell carcinoma – FNA (Photo credit: Pulmonary Pathology)Articles on NSCLC in Pharmaceutical Intelligence:http://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/ ...
NIGERIA: Credit guarantee company in Nigeria facilitates green Sukuk Ijarah issuance, Daily Trust reports TURKIYE: Turkish real estate investment trust company concludes lease certificate issuance worth TRY100 million (US$2.86 million) INDONESIA: Indonesian postal company plans to issue Sukuk worth IDR1 ...
AstraZenecaBioPharmaceuticals R&D executive vice-president Mene Pangalos said: “Tezspire is the first and only biologic approved in Europe for patients with severe asthma with no phenotype or biomarker limitation. How well do youreallyknow your competitors? Access the most comprehensive Company Profiles...
therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visitAstraZeneca.comand follow the Comp...
AstraZeneca will work with Alexion’s R&D team to develop the latter’s pipeline of 11 molecules. Credit: AstraZeneca. AstraZenecahas signed a definitive agreement to acquireglobal biopharmaceutical company Alexion Pharmaceuticalsfor $39bn or $175 a share. ...
AstraZeneca’s production and manufacture facility. Credit: AstraZeneca. AstraZenecamay initiate an additional global trial to evaluate the efficacy of its Covid-19 vaccine candidate, AZD1222, using a lower dosage. Co-invented by the University of Oxford and Vaccitech, AZD1222 uses a replication-...
AstraZeneca’s Farxiga receives fast track designation from the US FDA. Credit: Erik031. AstraZenecahas received fast track designation from the US Food and Drug Administration (FDA) for Farxiga (dapagliflozin) to treatchronic kidney disease (CKD). ...
In the DESTINY-Breast03 trial, Enhertu was demonstrated to lower disease progression or mortality risk by 72% in breast cancer patients. Credit: Nephron / Wikimedia. The US Food and Drug Administration (FDA) hasgrantedpriority review forAstraZenecaandDaiichi Sankyo’s Enhertu (trastuzumab derux...
AstraZeneca is working to boost access to the product via multiple supply deals. Credit: Bjoertvedt. The Australian Government has signed an agreement withAstraZenecafor the supply of the company’s Covid-19 vaccine candidate developed by the University of Oxford. ...